MaxCyte Inc.

Other News To Note.
BIOWORLD Today; 11/4/2009; 2938 words; ...terms were not disclosed. o Cognate Therapeutics Inc., of Sunnyvale, Calif., entered an agreement...products using a cell-loading system belonging to MaxCyte Inc., of Rockville, Md. MaxCyte will receive undisclosed up-front and milestone...

MaxCyte, Angiogene Agree To Develop Heart Failure Treatment.
BIOWORLD Today; 11/4/2009; 1025 words; Staff Writer MaxCyte Inc. entered a research agreement...of congestive heart failure. MaxCyte, of Rockville, Md., also has a collaboration with EntreMed Inc., its majority owner, in which MaxCyte is screening certain genes and...

House Subcommittee Hearing Debates SBIR Eligibility Rules.
BIOWORLD Today; 11/3/2009; 1420 words; ...the president and CEO of MaxCyte Inc., "but now those same...2943 and S.1263. MaxCyte, of Gaithersburg, Md...biotechnology industry." MaxCyte represents one of many...administration for AviGenics Inc., also testified...

Publication No. WO/2009/126789 Published on Oct. 15, Assigned to Maxcyte for Engineering, Therapeutic Composition Delivery (American Inventors)
US Fed News Service, Including US State News; 10/20/2009; 475 words; ...developed a engineering and delivery of therapeutic compositions of freshly isolated cells. The patent has been assigned to Maxcyte Inc., Gaithersburg, Md. According to an abstract posted by the World Intellectual Property Organization: "The present...

USPTO Issues Trademark MAXCYTE to MaxCyte for Scientific Apparatus
US Fed News Service, Including US State News; 10/9/2009; 353 words; ALEXANDRIA, Va., Oct. 9 -- MaxCyte Inc. Corp., Gaithersburg, Md., has been issued the trademark MAXCYTE (Reg. No. 3692551) by the USPTO. The trademark application (serial number 77718220) was filed on April 21 and was registered...